CA-AVIATRIX
25.8.2020 15:02:17 CEST | Business Wire | Press release
Aviatrix , the cloud network platform, today announced new capabilities to automate enterprise network infrastructure deployment and operations for organizations using the account factory feature of AWS Control Tower. Available now in AWS Marketplace , the integrated Aviatrix software serves as the network factory for newly provisioned accounts on Amazon Web Services (AWS). The solution helps enterprise organizations meet cloud governance and regulatory initiatives for their multi-account, multi-region cloud networks.
Join experts from Aviatrix and AWS on Thursday, August 27th as they host a live, online session to highlight the new AWS Control Tower and Aviatrix network factory capabilities. For more information or to register, go here .
“With AWS Control Tower, it only takes a few clicks for enterprise organizations to provision new AWS accounts that conform to company-wide policies,” said Chris Grusz, Director, AWS Marketplace, Amazon Web Services, Inc. “The Aviatrix cloud networking solution uniquely offers a network factory for AWS Control Tower. With AWS Control Tower account factory ensuring account control governance, customers will benefit from Aviatrix’s new capabilities that make certain the network infrastructure supporting those accounts is secure and correctly deployed every time.”
AWS Control Tower provides the easiest way to set up and govern new, secure, multi-account AWS environments. Additionally, AWS Service Catalog enables organizations to create and manage catalogs of approved IT services for use on AWS. The Aviatrix cloud network platform provides the prescriptive transit network architecture and operational visibility that meets enterprise cloud networking and security requirements. The Aviatrix software is able to create Amazon Virtual Private Clouds (Amazon VPCs), automate route table updates and ensure network correctness by preventing overlapping CIDRs, while also enforcing IT security controls through policy-based network segmentation. The integrated solution enables self-service delivery of new account infrastructure, provides detailed operational visibility, and helps ensure IT networking and security teams achieve compliance through a simple, automated workflow.
“In the journey to leverage cloud-based infrastructure we are always on the lookout for ways to streamline the automated delivery of services, in the simplest, most secure manner,” said Justin Donohoo, CTO at Observian. “The Aviatrix cloud network platform delivers the network architecture, advanced network, security controls, and operational visibility enterprises need. I view the integration of Aviatrix with AWS Control Tower as a natural evolution to streamline the delivery of new AWS infrastructure. Leveraging Aviatrix as the network factory and the AWS Control Tower account factory ensures that both AWS accounts and enterprise network infrastructure are deployed correctly and in compliance with corporate policies and industry regulations.”
Provisioning cloud network services is often easier than operationalizing them. AWS Control Tower customers who need to be in full control of their cloud network environment can also use the Aviatrix software to access the network intelligence they need – all in one place – instead of logging into multiple screens, services and management consoles to stitch together the network visibility they require. Aviatrix CoPilot – an available component of the integrated solution for AWS Control Tower - provides a global view of the cloud environment by leveraging intelligence and analytics from the Aviatrix cloud network platform combined with telemetry and network information gathered using native AWS APIs. CoPilot’s rich, intuitive visualizations provide actionable insights to practitioners by using dynamic multi-cloud topology maps, FlowIQ intelligent traffic flow analytics, global traffic heat maps, time series trend charts and a complete cloud network monitoring dashboard.
“AWS Control Tower is a leap forward for enterprise IT teams who are tasked with maintaining control over their networks, without becoming a bottleneck to their organization’s cloud agility and speed,” said Nauman Mustafa, VP of Solution Engineering at Aviatrix. “Regulatory compliance and corporate governance must be automated and adopted for the cloud era. The combination of AWS Control Tower and Aviatrix cloud network platform delivers the simplicity and automation along with enterprise visibility and control.”
Availability and How to Get Started
Aviatrix cloud network platform for AWS Control Tower is available immediately in AWS Marketplace . More technical information on the integrated solution - including how to get started - is available here . For a live demo or further information, please email info@aviatrix.com
About Aviatrix
Aviatrix cloud network platform delivers advanced networking, security and operational visibility required by enterprises with the simplicity and automation of cloud. More than 400 customers worldwide leverage Aviatrix and its proven multi-cloud network reference architecture to design, deploy and operate a repeatable network and security architecture that is consistent across any public cloud. Combined with the industry’s first and only multi-cloud networking certification (ACE ), Aviatrix is empowering IT to lead and accelerate the transformation to the cloud. Learn more at Aviatrix.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200825005365/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)30.1.2026 15:29:00 CET | Press release
Pending the European Commission decision, Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) will be the first PD-1 immunotherapy treatment for patients with advanced squamous cell carcinoma of the anal canal (SCAC) in EuropeGlobally, the prevalence of SCAC is estimated at around 1 or 2 cases per 100,000 people, with a higher incidence in women than in men1,2,3The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on data from the Phase 3 POD1UM-303/InterAACT2 trial which showed patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment4 Incyte (Nasdaq:INCY) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued a positive opinion recommending the approval of Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (
Mediawan to Acquire The North Road Company, Creating a New Global Independent Content Platform30.1.2026 13:32:00 CET | Press release
Mediawan, the leading independent European studio led by Pierre-Antoine Capton, co-founded by Capton, Xavier Niel and Matthieu Pigasse, today announced the signing of an agreement to acquire The North Road Company (“North Road”), the preeminent independent U.S.-based studio founded by Peter Chernin. The combination creates one of the world’s largest independent studios with major creative hubs in the five continents and capabilities spanning all genres, formats and audiences. Together, Mediawan and North Road will have a stronger ability to accelerate the development of powerful IP, foster fresh creative synergies through format adaptations and co-production opportunities, and deliver ever greater value to viewers, talent and partners worldwide. The acquisition brings together two of the most dynamic independent studios in the sector with world-class creative talent, premium IP, and the scale to deliver content at the highest level. In an industry undergoing significant consolidation,
BrightSign Powers Intelligent Signage Experiences at ISE 202630.1.2026 09:00:00 CET | Press release
The Latest Players and AI Capabilities Drive Captivating, Personalized, and Interactive Signage With more industries embracing the power of visual storytelling, BrightSign, the provider of the most advanced, capable, and trusted digital media players and operating system, will showcase the latest developments in digital signage technology at ISE 2026 in Barcelona, Spain from February 3-6, 2026. BrightSign’s latest innovations come to life at booth #4S-150 through interactive real-world demos featuring retail, QSR, transportation, and corporate use cases. Visitors can test new AI-powered object detection capabilities of BrightSign players, allowing them to pick up an object and see the content on the screen respond immediately. Booth activations will be powered by BrightSign’s reliable platform including bsn.Control, BrightSignOS™, brightAuthor connected, and its global partner ecosystem. “In today’s immersive, personalized and visual world, the stakes have never been higher for powerfu
Candela Ushers in a New Era of Aesthetic Innovation at IMCAS Paris With the Launch of the Glacē™ System30.1.2026 08:30:00 CET | Press release
Iconic Vbeam® Pro and Matrix™ Systems showcased ahead of broader commercial availability Candela, a global leader in energy-based aesthetic technologies, today announced the European launch of the Glacē™ System, a facial treatment platform that signals a bold new chapter for the company and the future of aesthetic medicine. In addition to the launch of the Glacē System, Candela will also showcase its Matrix system for radiofrequency-based skin renewal and its iconic Vbeam® Pro vascular treatment platform at IMCAS 2026. Both Matrix and VBeam Pro platforms are currently available in select EMEA markets and are expected to be comprehensively launched shortly, further strengthening Candela’s leadership in the energy-based device market. Unveiled at the IMCAS World Congress 2026, these launches underscore Candela’s continued commitment to delivering innovative, science-backed treatment solutions for high-demand patient needs. Candela leads the industry in clinical efficacy and safety, suppo
Merz Therapeutics Appoints Dan Staner as President, Region Europe30.1.2026 08:00:00 CET | Press release
Merz Therapeutics today announced the appointment of Dan Staner as President, Region Europe, effective February 1, 2026. In this role, Dan will oversee the company’s European business and drive regional growth. Dan will report directly to Merz Therapeutics Chief Executive Officer, Stefan König, and will join the Therapeutics Executive Team. His appointment reflects the company’s continued commitment to strengthening its leadership capabilities and accelerating its growth strategy across key European markets. “Dan brings a strong track record of building and scaling biopharmaceutical businesses across Europe,” said Stefan König, CEO of Merz Therapeutics. “His deep commercial, strategic, and regional leadership experience will be instrumental in advancing our growth ambitions, expanding patient access to our therapies, and further strengthening our presence in Europe. We are very pleased to welcome Dan to Merz Therapeutics.” Throughout his career, Dan has held senior leadership roles i
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
